These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

173 related items for PubMed ID: 2571171

  • 21. D-1/D-2 behavioural interactions in the rat involving striatal dopamine D-1 receptors.
    Starr MS.
    Eur J Pharmacol; 1988 Jul 14; 151(3):479-82. PubMed ID: 3265106
    [Abstract] [Full Text] [Related]

  • 22. Behavioural effects of selective dopamine D-1 and D-2 agonists and antagonists in guinea-pigs.
    Brent PJ.
    Psychopharmacology (Berl); 1991 Jul 14; 104(2):201-7. PubMed ID: 1831560
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. SKF 38393 potentiates yawning induced by LY 171555: further evidence against the autoreceptor hypothesis of yawning.
    Spina L, Longoni R, Mulas A, Di Chiara G.
    Psychopharmacology (Berl); 1989 Jul 14; 98(4):567-8. PubMed ID: 2570436
    [Abstract] [Full Text] [Related]

  • 25. Specific D1 and D2 dopamine agonists have synergistic effects in the 6-hydroxydopamine circling model in the rat.
    Rouillard C, Bédard PJ.
    Neuropharmacology; 1988 Dec 14; 27(12):1257-64. PubMed ID: 2907616
    [Abstract] [Full Text] [Related]

  • 26. Bromocriptine induces marked locomotor stimulation in dopamine-depleted mice when D-1 dopamine receptors are stimulated with SKF38393.
    Jackson DM, Hashizume M.
    Psychopharmacology (Berl); 1986 Dec 14; 90(1):147-9. PubMed ID: 3094056
    [Abstract] [Full Text] [Related]

  • 27. Behavioural role of dopamine D1 receptors in the reserpine-treated mouse.
    Starr BS, Starr MS, Kilpatrick IC.
    Neuroscience; 1987 Jul 14; 22(1):179-88. PubMed ID: 2957609
    [Abstract] [Full Text] [Related]

  • 28. Drugs acting at D-1 and D-2 dopamine receptors induce identical purposeless chewing in rats which can be differentiated by cholinergic manipulation.
    Collins P, Broekkamp CL, Jenner P, Marsden CD.
    Psychopharmacology (Berl); 1991 Jul 14; 103(4):503-12. PubMed ID: 1676528
    [Abstract] [Full Text] [Related]

  • 29. Why does clozapine stimulate the motor activity of reserpine-pretreated rats when combined with a dopamine D1 receptor agonist?
    Jackson DM, Mohell N, Bengtsson A, Malmberg A.
    Eur J Pharmacol; 1995 Aug 25; 282(1-3):137-44. PubMed ID: 7498268
    [Abstract] [Full Text] [Related]

  • 30. Locomotor behaviour of selective dopamine agonists in mice: is endogenous dopamine the only catecholamine involved?
    Pichler L, Pifl C.
    J Pharm Pharmacol; 1989 Oct 25; 41(10):690-3. PubMed ID: 2575146
    [Abstract] [Full Text] [Related]

  • 31. Permissive role of D-1 receptor stimulation for the expression of D-2 mediated behavioral responses: a quantitative phenomenological study in rats.
    Longoni R, Spina L, Di Chiara G.
    Life Sci; 1987 Nov 02; 41(18):2135-45. PubMed ID: 2959833
    [Abstract] [Full Text] [Related]

  • 32. Bromocriptine induces climbing behaviour: possible D-1 or D-2 dopamine receptor involvement.
    Zarrindast MR, Shahed-Dirin K.
    Psychopharmacology (Berl); 1990 Nov 02; 100(2):275-80. PubMed ID: 2305016
    [Abstract] [Full Text] [Related]

  • 33. Blockade of both D-1 and D-2 dopamine receptors may induce catalepsy in mice.
    Zarrindast MR, Habibi-Moini S.
    Gen Pharmacol; 1991 Nov 02; 22(6):1023-6. PubMed ID: 1687392
    [Abstract] [Full Text] [Related]

  • 34. Motor actions of 7-OH-DPAT in normal and reserpine-treated mice suggest involvement of both dopamine D2 and D3 receptors.
    Starr MS, Starr BS.
    Eur J Pharmacol; 1995 Apr 24; 277(2-3):151-8. PubMed ID: 7493603
    [Abstract] [Full Text] [Related]

  • 35. Dopamine receptors and sensorimotor behavior in MPTP-treated mice.
    Weihmuller FB, Hadjiconstantinou M, Bruno JP.
    Behav Brain Res; 1990 May 28; 38(3):263-73. PubMed ID: 1973042
    [Abstract] [Full Text] [Related]

  • 36. Dopaminergic mechanisms and motor function: characterization of D-1 and D-2 dopamine receptor interactions.
    Barone P, Davis TA, Braun AR, Chase TN.
    Eur J Pharmacol; 1986 Apr 09; 123(1):109-14. PubMed ID: 2872071
    [Abstract] [Full Text] [Related]

  • 37. Post-training dopamine receptor agonists and antagonists affect memory storage in mice irrespective of their selectivity for D1 or D2 receptors.
    Castellano C, Cestari V, Cabib S, Puglisi-Allegra S.
    Behav Neural Biol; 1991 Nov 09; 56(3):283-91. PubMed ID: 1684703
    [Abstract] [Full Text] [Related]

  • 38. 6-hydroxydopamine treatments enhance behavioral responses to intracerebral microinjection of D1- and D2-dopamine agonists into nucleus accumbens and striatum without changing dopamine antagonist binding.
    Breese GR, Duncan GE, Napier TC, Bondy SC, Iorio LC, Mueller RA.
    J Pharmacol Exp Ther; 1987 Jan 09; 240(1):167-76. PubMed ID: 3100767
    [Abstract] [Full Text] [Related]

  • 39. Effects of locally applied D-1 and D-2 receptor agonists and antagonists studied with brain dialysis.
    Imperato A, Di Chiara G.
    Eur J Pharmacol; 1988 Nov 08; 156(3):385-93. PubMed ID: 2905668
    [Abstract] [Full Text] [Related]

  • 40. Involvement of dopamine receptor subtypes in mouse thermoregulation.
    Zarrindast MR, Tabatabai SA.
    Psychopharmacology (Berl); 1992 Nov 08; 107(2-3):341-6. PubMed ID: 1535446
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.